CU Medical Systems, Inc. (KOSDAQ:115480)
South Korea · Delayed Price · Currency is KRW 2,055.00
-155.00 (-7.01%)
At close: May 29, 2026
CU Medical Systems Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 3,185 | 819.2 | -3,204 | -8,204 | 9,425 | -13,981 |
Depreciation & Amortization | 3,407 | 3,293 | 2,658 | 1,935 | 1,651 | 1,945 |
Loss (Gain) From Sale of Assets | 0 | -3.5 | -8.7 | -119.88 | -861.77 | 10.49 |
Asset Writedown & Restructuring Costs | - | - | 1,055 | 2,781 | 370.57 | 5,267 |
Loss (Gain) From Sale of Investments | 8,297 | 8,585 | 9,214 | 9,637 | 1,024 | 8,046 |
Provision & Write-off of Bad Debts | 109.49 | 29.58 | -875.72 | 1,701 | -154.21 | -389.72 |
Other Operating Activities | 1,726 | 1,912 | 1,215 | 474.15 | 2,401 | 8,068 |
Change in Accounts Receivable | -1,160 | -3,820 | -641.81 | -2,005 | -4,348 | -2,165 |
Change in Inventory | -2,335 | -715.39 | 2,966 | 1,358 | -4,887 | -834.41 |
Change in Accounts Payable | 168.52 | -705.14 | -11.97 | 857.79 | 358.8 | 956.05 |
Change in Unearned Revenue | 253.05 | 147.4 | -11.5 | - | 64.26 | -524.64 |
Change in Other Net Operating Assets | -293.32 | 144.75 | 1,717 | -139.69 | -1,923 | -5,906 |
Operating Cash Flow | 13,356 | 9,687 | 14,072 | 8,275 | 3,121 | 490.43 |
Operating Cash Flow Growth | -11.05% | -31.16% | 70.06% | 165.11% | 536.46% | -94.17% |
Capital Expenditures | -1,049 | -1,058 | -20,056 | -6,382 | -11,586 | -5,186 |
Sale of Property, Plant & Equipment | 21.97 | 3.5 | 29.84 | 31.36 | - | 24.45 |
Cash Acquisitions | -19,839 | -440.23 | - | - | - | - |
Divestitures | - | - | - | 10 | - | - |
Sale (Purchase) of Intangibles | -235.77 | -235.77 | -6.5 | -89.14 | -18.63 | 49.65 |
Investment in Securities | 7,787 | 4,378 | -11,577 | -4,783 | -5,652 | 2,735 |
Other Investing Activities | -1,857 | -3,131 | -260.16 | -308.62 | 2,737 | 231.97 |
Investing Cash Flow | -15,392 | -537.62 | -31,870 | -11,476 | -13,969 | -1,518 |
Short-Term Debt Issued | - | - | 2,050 | 1,000 | 8.18 | 11,102 |
Long-Term Debt Issued | - | - | 30,000 | 6,694 | 10,620 | 5,480 |
Total Debt Issued | 15,800 | - | 32,050 | 7,694 | 10,628 | 16,582 |
Short-Term Debt Repaid | - | -2,346 | -1,000 | - | -1,221 | -14,130 |
Long-Term Debt Repaid | - | -1,873 | -18,628 | -656.28 | -4,480 | -11,222 |
Total Debt Repaid | -2,962 | -4,219 | -19,628 | -656.28 | -5,701 | -25,352 |
Net Debt Issued (Repaid) | 12,838 | -4,219 | 12,422 | 7,037 | 4,927 | -8,770 |
Issuance of Common Stock | - | - | 8,009 | - | 373.3 | 19,009 |
Repurchase of Common Stock | -769.33 | - | -71.24 | - | - | - |
Other Financing Activities | -260 | - | 724.37 | -0 | - | - |
Financing Cash Flow | 11,809 | -4,219 | 21,085 | 7,037 | 5,300 | 10,239 |
Foreign Exchange Rate Adjustments | -51.55 | 103.25 | 363.21 | -70.4 | -191.36 | -12.01 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -365.2 |
Net Cash Flow | 9,721 | 5,034 | 3,650 | 3,766 | -5,739 | 8,834 |
Free Cash Flow | 12,308 | 8,629 | -5,984 | 1,893 | -8,465 | -4,696 |
Free Cash Flow Margin | 22.52% | 17.89% | -14.73% | 4.53% | -18.03% | -13.26% |
Free Cash Flow Per Share | 837.20 | 712.86 | -588.26 | 197.93 | -937.51 | -692.09 |
Cash Interest Paid | 1,392 | 1,413 | 1,078 | 288.48 | 329.48 | 637.64 |
Cash Income Tax Paid | 521.6 | 469.48 | 277.37 | 1,377 | 347.03 | 398.71 |
Levered Free Cash Flow | -1,705 | 5,352 | -9,027 | -4,944 | 11,830 | 686.73 |
Unlevered Free Cash Flow | -800.06 | 6,255 | -8,310 | -4,741 | 12,114 | 1,397 |
Change in Working Capital | -3,367 | -4,948 | 4,018 | 70.62 | -10,734 | -8,474 |